Evidence map›Paper›PMID 32973069›Full record

ReviewGut2021

Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.

Savio George Barreto, Aida Habtezion, Anna Gukovskaya, Aurelia Lugea, Christie Jeon, Dhiraj Yadav, Peter Hegyi, Viktória Venglovecz, Robert Sutton, Stephen J Pandol

Open access · bronzeAbstract readReview
In one paragraph

Review in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 3 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 3 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Effect of Dexmedetomidine on Mortality in Patients with Acute Pancreatitis: A Retrospective Propensity Score Matching Analysis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Savio George BarretoDivision of Surgery and Perioperative Medicine, Flinders Medical Center, Bedford Park, Adelaide, South Australia, Australia.ORCID 0000-0002-4999-5657
Aida HabtezionDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-4473-006X
Anna GukovskayaDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
Aurelia LugeaDivision of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Christie JeonDivision of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA.ORCID 0000-0002-5739-2477
Dhiraj YadavDivision of Gastroenterology & Hepatology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Peter HegyiFirst Department of Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.ORCID 0000-0003-0399-7259
Viktória VengloveczDepartment of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
Robert SuttonInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.ORCID 0000-0001-6600-562X
Stephen J PandolDivision of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA Stephen.Pandol@cshs.org.
Cedars-Sinai Medical Center · USUniversity of Szeged · HUFlinders University · AUStanford University · USUniversity of Liverpool · GBUniversity of Pittsburgh Medical Center · USWest Los Angeles College · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
Vector and Human Acinar CoreP01DK098108 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PANDOL, STEPHEN J. · 2014 to 2018
$8.1M
UPMC Clinical Center for the Study of Chronic Pancreatitis and DiabetesU01DK108306 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Frederico G. S. Toledo, Dhiraj Yadav · 2015 to 2026
$6.4M
The Stanford Clinical Center for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerU01DK108300 · NIDDK · STANFORD UNIVERSITY · PI Sohail Z Husain, Walter Gwang-Up Park · 2015 to 2026
$6.3M
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes - Administrative SupplementU01DK108314 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Mark Goodarzi, Stephen J. Pandol · 2015 to 2026
$6.1M
Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancerP01CA236585 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EIBL, GUIDO ERWIN MICHAEL · 2020 to 2024
$5.6M
Role of hemeoxygenase-1 in experimental acute pancreatitisR01DK092421 · NIDDK · STANFORD UNIVERSITY · PI HABTEZION, AIDA · 2011 to 2020
$3.5M
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis ConsortiumU01DK127403 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Mark Goodarzi, Stephen J. Pandol · 2020 to 2026
$2.5M
Targeting protein kinase D in alcoholic pancreatitisR01AA024464 · NIAAA · CEDARS-SINAI MEDICAL CENTER · PI PANDOL, STEPHEN J., YUAN, JINGZHEN · 2016 to 2020
$2.0M
Mitochondrial Dysfunction, Permeability Transition Pore, and Acute PancreatitisI01BX000774 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI GUKOVSKAYA, ANNA S. · 2011 to 2014
–
Cell Death and Autophagy in Chronic PancreatitisI01BX004306 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI GUKOVSKAYA, ANNA S. · 2018 to 2021
–
Smoking, Alcohol Abuse and the PancreasI01BX001484 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI PANDOL, STEPHEN J. · 2012 to 2015
–
BLRD VA I01 BX000774BLRD VA I01 BX001484BLRD VA I01 BX004306Department of Health 15/20/01Medical Research CouncilNCI NIH HHS P01 CA236585NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA024464NIDDK NIH HHS P01 DK098108NIDDK NIH HHS R01 DK092421NIDDK NIH HHS U01 DK108300NIDDK NIH HHS U01 DK108306NIDDK NIH HHS U01 DK108314NIDDK NIH HHS U01 DK127403
6 · The paper itself

Abstract

Acute pancreatitis (AP), an acute inflammatory disorder of the exocrine pancreas, is one of the most common gastrointestinal diseases encountered in emergency departments with no specific treatments. Laboratory-based research has formed the cornerstone of endeavours to decipher the pathophysiology of AP, because of the limitations of such study in human beings. While this has provided us with substantial understanding, we cannot answer several pressing questions. These are: (a) Why is it that only a minority of individuals with gallstones, or who drink alcohol excessively, or are exposed to other causative factors develop AP? (b) Why do only some develop more severe manifestations of AP with necrosis and/or organ failure? (c) Why have we been unable to find an effective therapeutic for AP? This manuscript provides a state-of-the-art review of our current understanding of the pathophysiology of AP providing insights into the unanswered clinical questions. We describe multiple protective factors operating in most people, and multiple stressors that in a minority induce AP, independently or together, via amplification loops. We present testable hypotheses aimed at halting progression of severity for the development of effective treatments for this common unpredictable disease.

Indexed as

HumansPancreatitisacute pancreatitisepidemiologypancreatic disorderspancreatic islet cellpancreatic secretion

Identifiers

PMID32973069
PMCPMC7816970
OpenAlexW3088096263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.